PCRX financials
Pacira BioSciences (PCRX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PCRX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $726.41M | $576.66M | $33.30M | $7.03M | 0.16 |
| 2024 | $700.97M | $530.54M | -$73.37M | -$99.56M | -2.15 |
| 2023 | $674.98M | $490.31M | $87.67M | $41.95M | 0.89 |
| 2022 | $666.82M | $467.53M | $60.02M | $15.91M | 0.34 |
| 2021 | $541.53M | $401.28M | $89.92M | $41.98M | 0.92 |
| 2020 | $429.65M | $312.32M | $46.35M | $145.52M | 3.33 |
- PCRX revenue was $726.41M in fiscal 2025, net income $7.03M.
Updated 2026-11-03 11:33 UTC